Compare TOI & WILC Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | TOI | WILC |
|---|---|---|
| Founded | 2007 | 1994 |
| Country | United States | Israel |
| Employees | 641 | N/A |
| Industry | Medical/Nursing Services | Food Distributors |
| Sector | Health Care | Consumer Discretionary |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 579.9M | 487.6M |
| IPO Year | N/A | 2001 |
| Metric | TOI | WILC |
|---|---|---|
| Price | $5.87 | $31.55 |
| Analyst Decision | Strong Buy | |
| Analyst Count | 3 | 0 |
| Target Price | ★ $6.67 | N/A |
| AVG Volume (30 Days) | ★ 1.8M | 995.0 |
| Earning Date | 05-07-2026 | 05-18-2026 |
| Dividend Yield | N/A | ★ 2.70% |
| EPS Growth | N/A | N/A |
| EPS | N/A | N/A |
| Revenue | N/A | N/A |
| Revenue This Year | $30.15 | N/A |
| Revenue Next Year | $25.77 | N/A |
| P/E Ratio | ★ N/A | $13.45 |
| Revenue Growth | N/A | N/A |
| 52 Week Low | $2.32 | $17.66 |
| 52 Week High | $6.11 | $37.35 |
| Indicator | TOI | WILC |
|---|---|---|
| Relative Strength Index (RSI) | 64.43 | 41.93 |
| Support Level | $3.28 | $30.00 |
| Resistance Level | N/A | $33.72 |
| Average True Range (ATR) | 0.37 | 0.77 |
| MACD | 0.02 | -0.09 |
| Stochastic Oscillator | 78.10 | 41.67 |
The Oncology Institute Inc offers oncology care and treatment services to patients through several clinics located across the United States. It offers services such as infusion chemotherapy, oral drug chemotherapy, hospice and palliative care, autologous stem cell transplants, outpatient blood product transfusions, patient navigator programs, radiation oncology, and others on a fee or value-based model. Additionally, the company enrolls patients in clinical trials, where appropriate. The company has three operating segments: Specialty Pharmacy, Patient Services, and Clinical Trials and Other. Maximum revenue is generated from the Specialty Pharmacy segment, which operates specialty and retail pharmacies providing IV-infused, oral, injectable, and other medications for oncology treatment.
G. Willi-Food International Ltd is an Israeli-based company specializing in high-quality, great-tasting kosher food products. The company is engaged, directly and through subsidiaries, in the design, import, marketing and distribution of a variety of over 650 food products. The principal product line includes Canned Vegetables and Pickles, Canned Fish, Canned Fruit, Edible Oils, Dairy and Dairy Substitute Products, Cereals, rice and pastas, and Other Products. The company has one reportable segment: Import- export, marketing and distribution of food products. The majority of the company's revenue is derived from the sale of Dairy and Dairy Substitute Products.